Illumina Inc
(NAS:ILMN)
$
146.17
-1.45 (-0.98%)
Market Cap: 23.18 Bil
Enterprise Value: 25.15 Bil
PE Ratio: 0
PB Ratio: 10.87
GF Score: 80/100 Illumina Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023 / 04:55PM GMT
Release Date Price:
$150.42
(-2.28%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
All right. Hey, everyone. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. It's my pleasure to host Illumina today. And from the company, we have Joydeep Goswami, CFO; and Salli Schwartz, Head of Investor Relations. Welcome, guys.
Joydeep Goswami
Illumina, Inc. - CFO, Chief Strategy & Corporate Development Officer
Thank you.
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
Questions & Answers
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
So maybe to kick things off, Joydeep, big news last week with Jacob Thaysen's appointment as CEO. This pick seems to signal a fresh start for Illumina with a renewed
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot